These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 15209744

  • 21. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
    Larghi A, Lightdale CJ, Ross AS, Fedi P, Hart J, Rotterdam H, Noffsinger A, Memeo L, Bhagat G, Waxman I.
    Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
    [Abstract] [Full Text] [Related]

  • 22. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
    Weston AP, Badr AS, Hassanein RS.
    Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
    [Abstract] [Full Text] [Related]

  • 23. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem.
    Rusch VW, Levine DS, Haggitt R, Reid BJ.
    Cancer; 1994 Aug 15; 74(4):1225-9. PubMed ID: 8055442
    [Abstract] [Full Text] [Related]

  • 24. Prevalence and Natural History of Barrett's Esophagus in Lung Transplant: A Single-Center Experience.
    Biswas Roy S, Banks P, Kunz M, Ipsen TR, Masuda T, Mittal SK, Smith MA, Bremner RM.
    Ann Thorac Surg; 2019 Apr 15; 107(4):1017-1023. PubMed ID: 30481513
    [Abstract] [Full Text] [Related]

  • 25. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.
    Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE.
    Clin Gastroenterol Hepatol; 2006 May 15; 4(5):566-72. PubMed ID: 16630761
    [Abstract] [Full Text] [Related]

  • 26. Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia.
    Falk GW, Rice TW, Goldblum JR, Richter JE.
    Gastrointest Endosc; 1999 Feb 15; 49(2):170-6. PubMed ID: 9925694
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Short-segment Barrett's esophagus associated with high-grade dysplasia.
    Morita K, Fujimori T, Ono Y, Masuyama H, Nakamura T, Terano A.
    J Gastroenterol; 2002 Feb 15; 37(12):1083-5. PubMed ID: 12522544
    [No Abstract] [Full Text] [Related]

  • 31. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies.
    Downs-Kelly E, Mendelin JE, Bennett AE, Castilla E, Henricks WH, Schoenfield L, Skacel M, Yerian L, Rice TW, Rybicki LA, Bronner MP, Goldblum JR.
    Am J Gastroenterol; 2008 Sep 15; 103(9):2333-40; quiz 2341. PubMed ID: 18671819
    [Abstract] [Full Text] [Related]

  • 32. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit.
    Moss A, Bourke MJ, Hourigan LF, Gupta S, Williams SJ, Tran K, Swan MP, Hopper AD, Kwan V, Bailey AA.
    Am J Gastroenterol; 2010 Jun 15; 105(6):1276-83. PubMed ID: 20179694
    [Abstract] [Full Text] [Related]

  • 33. Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.
    Guarner-Argente C, Buoncristiano T, Furth EE, Falk GW, Ginsberg GG.
    Gastrointest Endosc; 2013 Feb 15; 77(2):190-9. PubMed ID: 23317687
    [Abstract] [Full Text] [Related]

  • 34. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium.
    Gopal DV, Lieberman DA, Magaret N, Fennerty MB, Sampliner RE, Garewal HS, Falk GW, Faigel DO.
    Dig Dis Sci; 2003 Aug 15; 48(8):1537-41. PubMed ID: 12924649
    [Abstract] [Full Text] [Related]

  • 35. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z, Mickevicius A, Kiudelis M.
    Zentralbl Chir; 2004 Apr 15; 129(2):99-103. PubMed ID: 15106039
    [Abstract] [Full Text] [Related]

  • 36. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
    Asthana N, Mandich D, Ligato S.
    Am J Surg Pathol; 2008 Oct 15; 32(10):1581-5. PubMed ID: 18724240
    [Abstract] [Full Text] [Related]

  • 37. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
    Provenzale D, Schmitt C, Wong JB.
    Am J Gastroenterol; 1999 Aug 15; 94(8):2043-53. PubMed ID: 10445526
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia.
    Edwards MJ, Gable DR, Lentsch AB, Richardson JD.
    Ann Surg; 1996 May 15; 223(5):585-9; discussion 589-91. PubMed ID: 8651749
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.